Navigation Links
Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum
Date:10/17/2010

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the Nasdaq, then Simcere, a pharmaceutical company based in Jiangsu Province, listed on the NYSE, announced a 50.8% stake in Ealong Biotech and took control of the latter, and finally Novartis, the world-famous pharmaceutical company headquartered in Switzerland, acquired an 85.0% equity in Tianyuan Bio-Pharmaceutical, a vaccine producer, for RMB850M. These deals indicate that the investors and foreign pharmaceutical giants have not slowed down their pace to enter China's vaccine market, even in the face of this economic recession.

Hosted by Global Leaders Institute, world vaccine industry leaders convened at VacChina 2010 on Sept 15 and 16 in Shanghai. The two-day executive summit featured over 30 speakers and attendances from top executives including Junfang Gao, GM of Changchun Changsheng Life Science and An Kang, Chairman of the Board from Hualan Bio to share views on the latest China vaccine industry regulatory environment, research capabilities, market trends, and status of technology applications etc. Well attended by over 200 attendees from vaccine producers home and abroad including 6 main institutes of biological products in China and top China vaccine manufacturers like Zhejiang Tianyuan, Chengda Bio, Shanghai United Cell, Wison Bio, Walvax, Tasly and Innovax gathered under the same roof to look for partnering opportunities, VacChina 2010 was undoubtedly the most high end vaccine meeting held in China this year. Besides, thanks to over 20 corporate sponsors showcasing their state of the art vaccine R&D technologies at the event, VacChina 2010 is also a premier platform for various technology providers presenting their latest advancements in vaccine bioreactor, cell culture, single use and purification.

As a top gold sponsor in the grand event, Pall Life Sciences introduced ground-breaking technologies and expanded service offerings to help manufacturers improve their vaccine products and processes. These technologies include Single use system, disposable depth filter with the Stax system, membrane chromatography-Mustang, various advance designed sterile filters and the cutting-edge integrity test instrument -- Flowstar IV.  All of these could be used as total solution to be incorporated into vaccine production, the benefits to the manufacturers are to reduce the contaminant as low as possible, eliminate the cross contamination by containment and save the production cost as much as possible, and thus all these benefits will improve the vaccine's quality and safety and allow people in the world to live a better life.

About Global Leaders Institute

Global Leaders Institute is the producer and organizer of top-level business events. We focus on the development and operation of the strategic, market leading business conference. We focus on the specialty spirit and professional attainment. We focus on value creation for our client. We provide 60 annual conferences across energy, finance, transportation, life science, real estate, telecom and media, etc. each year.


'/>"/>
SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports
2. Consumer Reports Flu Poll: Approximately Three Out of 10 Health Care Workers Living in a Bubble, Not Getting Flu Vaccine
3. Vaccine and Medication Safety are Parents Top Research Priorities
4. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
5. Sanofi Pasteur and U.S. Department of Health and Human Services Enter Into Agreement for Pandemic Vaccine Preparedness
6. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
7. Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports
8. immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
9. Ukrainian Government Unit Sues in U.S. - Alleges Corrupt Scheme in Vaccine Purchases
10. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
11. Generex Announces Presentations of Novel Vaccine Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):